Document Type : Original Paper
Authors
- Atiyeh Ataei 1
- Peyman Eshraghi 2
- Atiyeh Eslahi 3
- Zeinab Khazaei 1
- Masoome Alerasool 4
- Sara Jamali 1
- Faranak Ghadamyari 1
- Majid Mojarrad 5
1 1 Medical Genetic Laboratory, Genetic Foundation of Khorasan Razavi, Mashhad, Islamic Republic of Iran
2 2 Department of Pediatric Endocrinology, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Islamic Republic of Iran
3 3 Department of Medical Genetics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Islamic Republic of Iran
4 1 Medical Genetic Laboratory, Genetic Foundation of Khorasan Razavi, Mashhad, Islamic Republic of Iran 3 Department of Medical Genetics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Islamic Republic of Iran
5 1 Medical Genetic Laboratory, Genetic Foundation of Khorasan Razavi, Mashhad, Islamic Republic of Iran 3 Department of Medical Genetics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Islamic Republic of Iran 4 Medical Genetics Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Islamic Republic of Iran
Abstract
5 α-Reductase type 2 deficiency, caused by mutations in the SRD5A2
gene, leads to an autosomal recessive disorder of sex differentiation (DSD) in 46, XY persons. A 2 years old female with ambiguous genitalia was referred to Genetic Foundation of Khorasan Razavi (GFKR), IRAN. Her secondary sex characteristics, level of sex hormones, the development of reproductive system and karyotype were assessed. Whole-exome sequencing (WES) was preformed to find the pathogenic genetic variations associated with ambiguous genitalia. Also, Sanger sequencing was used to verify the WES results in the patient. Segregation analysis was performed to confirm mutation in the parents and other relatives. Physical examination and ultrasonography data demonstrated that the patient have testis in the left labium majus and right groin but does not have a uterus or ovaries. Sex hormone examination revealed that hormone therapy was successful and the level of FSH, LH, testosterone, and dihydrotestostron (DHT) was 2.8 mlu/ml, 2.4 mlu/ml, 15ng/dl, 21pg/ml, respectively. Cytogenetic study showed 46XY compatible to normal male karyotype. According to WES result and Sanger sequencing a homozygote loss of function mutation (c.16C>T; p.Gln6Ter) in SRD5A2 has been detected. Segregation analysis confirmed the mutation in the family. Homozygote mutation in SRD5A2 is the main cause of disorders of sex development in this family.
Keywords
Main Subjects
- Gomez-Lobo V, Oelschlager A-MA. Disorders of sexual development in adult women. J Obstet Gynaecol. 2016;128(5):1162.
- Wilson JD, Griffin JE, Russell DW. Steroid 5α-reductase 2 deficiency. Endocr. Rev. 1993;14(5):577-93.
- Griffin JE, Leshin M, Wilson JD. Androgen resistance syndromes. Am. J. Physiol. Endocrinol. 1982;243(2):E81-E7.
- Vilchis F, Valdez E, Ramos L, García R, Gómez R, Chávez B. Novel compound heterozygous mutations in the SRD5A2 gene from 46, XY infants with ambiguous external genitalia. J. Hum. Genet. 2008;53(5):401-6.
- Blaschko SD, Cunha GR, Baskin LS. Molecular mechanisms of external genitalia development. Differentiation. 2012;84(3):261-8.
- Sasaki G, Nakagawa K, Hashiguchi A, Hasegawa T, Ogata T, Murai M. Giant seminoma in a patient with 5α-reductase type 2 deficiency. J. Urol. 2003;169(3):1080-1.
- Imperato-McGinley J. 5α-Reductase-2 deficiency and complete androgen insensitivity: lessons from nature. Pediatric Gender Assignment: Springer; 2002. p. 121-34.
- Achermann JC, Domenice S, Bachega TA, Nishi MY, Mendonca BB. Disorders of sex development: effect of molecular diagnostics. Nat. Rev. Endocrinol. 2015;11(8):478.
- Baetens D, Verdin H, De Baere E, Cools M. Update on the genetics of differences of sex development (DSD). Best Pract. Res. Clin. Endocrinol. Metab. 2019;33(3):101271.
- Sahakitrungruang T, Wacharasindhu S, Yeetong P, Snabboon T, Suphapeetiporn K, Shotelersuk V. Identification of mutations in the SRD5A2 gene in Thai patients with male pseudohermaphroditism. Fertil. Steril. 2008;90(5):2015. e11-. e15.
- Ko JM, Cheon C-K, Kim G-H, Kim SH, Kim KS, Yoo H-W. Clinical characterization and analysis of the SRD5A2 gene in six Korean patients with 5α-reductase type 2 deficiency. Horm Res Paediatr. 2010;73(1):41-8.
- Wang Y, Li Q, Xu J, Liu Q, Wang W, Lin Y, et al. Mutation analysis of five candidate genes in Chinese patients with hypospadias. Eur. J. Hum. Genet. 2004;12(9):706-12.
- Zhang M, Yang J, Zhang H, Ning G, Li X, Sun S. A novel SRD5A2 mutation with loss of function identified in Chinese patients with hypospadias. Horm Res Paediatr. 2011;76(1):44-9.
- Rahimi M, Ghanbari M, Fazeli Z, Rouzrokh M, Omrani S, Mirfakhraie R, et al. Association of SRD5A2 gene mutations with risk of hypospadias in the Iranian population. J. Endocrinol. Invest. 2017;40(4):391-6.
)